• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News

Our short URL is biophar.ma

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media Logo

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Amgen

asthma
Posted inAutoimmune Diseases, New Drugs, Regulatory

Tezspire: Effective Treatment for Severe Uncontrolled Asthma

Tezepelumab is a powerful new drug for asthma, invented by Amgen and AstraZeneca, with a completely new mechanism of action.

heart
Posted inClinical Trials, Metabolism

Merck & Co. Has Come Up With Very Powerful Pill Against ‘Bad’ Cholesterol

…that is beating all the competitors to the punch.

Bemarituzumab: Breakthrough in Gastric Cancer Treatment
Posted inClinical Trials, Oncology

Bemarituzumab: Breakthrough in Gastric Cancer Treatment

A new and effective targeted therapy, being developed by Five Prime Therapeutics and Amgen, for a deadly cancer disease in the past decade.

Lungs.
Posted inClinical Trials, In the Pipeline, Oncology, Regulatory

Small Cell Lung Cancer: Let Immunotherapy Help!

A deadly disease and modern pharmacological attempts to treat it.

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2022 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News